Profiel
Mira Leiwant is Senior VP-Quality, Regulatory & Clinical Affairs at Anika Therapeutics, Inc. since 2019.
Former roles include Senior Director-Regulatory & Quality Engineering at LifeCell Corp.
and Vice President-Regulatory Affairs at BTG International, Inc. Education includes undergraduate and graduate degrees from Cornell University, conferred in 1997 and 1998 respectively.
Actieve functies van Mira Leiwant
| Bedrijven | Functie | Begin |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 14-10-2019 |
Eerdere bekende functies van Mira Leiwant
| Bedrijven | Functie | Einde |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Algemeen Adviseur | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Opleiding van Mira Leiwant
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
















